Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.39 Billion CNY | 8.49% |
| 2022 | 2.97 Billion CNY | 3.52% |
| 2021 | 2.87 Billion CNY | 45.39% |
| 2020 | 1.97 Billion CNY | 20.69% |
| 2019 | 1.63 Billion CNY | 24.1% |
| 2018 | 1.32 Billion CNY | 39.33% |
| 2017 | 947.39 Million CNY | 55.7% |
| 2016 | 608.48 Million CNY | 12.35% |
| 2015 | 541.59 Million CNY | 6.58% |
| 2014 | 508.15 Million CNY | 2.31% |
| 2013 | 496.68 Million CNY | 27.36% |
| 2012 | 389.99 Million CNY | 27.72% |
| 2011 | 305.33 Million CNY | 32.17% |
| 2010 | 231.01 Million CNY | 51.36% |
| 2009 | 152.62 Million CNY | -9.16% |
| 2008 | 168.01 Million CNY | 14.17% |
| 2007 | 147.15 Million CNY | 16.3% |
| 2006 | 126.52 Million CNY | -4.22% |
| 2005 | 132.1 Million CNY | 71.4% |
| 2004 | 77.07 Million CNY | -13.82% |
| 2003 | 89.43 Million CNY | 0.62% |
| 2002 | 88.88 Million CNY | 9.78% |
| 2001 | 80.96 Million CNY | -3.68% |
| 2000 | 84.05 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 1.12 Billion CNY | 27.24% |
| 2024 Q2 | 884.88 Million CNY | -22.46% |
| 2024 Q1 | 1.14 Billion CNY | 167.3% |
| 2023 Q2 | 922.92 Million CNY | -1.78% |
| 2023 Q3 | 1.03 Billion CNY | 12.31% |
| 2023 FY | 3.22 Billion CNY | 8.49% |
| 2023 Q1 | 939.62 Million CNY | 92.13% |
| 2023 Q4 | 426.94 Million CNY | -58.81% |
| 2022 FY | 2.97 Billion CNY | 3.52% |
| 2022 Q4 | 489.04 Million CNY | -44.98% |
| 2022 Q1 | 832.11 Million CNY | 89.7% |
| 2022 Q2 | 765.67 Million CNY | -7.98% |
| 2022 Q3 | 888.87 Million CNY | 16.09% |
| 2021 FY | 2.87 Billion CNY | 45.39% |
| 2021 Q1 | 683.33 Million CNY | 75.59% |
| 2021 Q4 | 438.65 Million CNY | -59.76% |
| 2021 Q3 | 1.09 Billion CNY | 64.6% |
| 2021 Q2 | 662.31 Million CNY | -3.08% |
| 2020 Q2 | 476.08 Million CNY | -14.77% |
| 2020 Q3 | 553.26 Million CNY | 16.21% |
| 2020 Q4 | 389.16 Million CNY | -29.66% |
| 2020 FY | 1.97 Billion CNY | 20.69% |
| 2020 Q1 | 558.57 Million CNY | 73.17% |
| 2019 Q4 | 322.55 Million CNY | -23.25% |
| 2019 Q3 | 420.25 Million CNY | 2.33% |
| 2019 FY | 1.63 Billion CNY | 24.1% |
| 2019 Q1 | 484.63 Million CNY | 107.26% |
| 2019 Q2 | 410.69 Million CNY | -15.26% |
| 2018 FY | 1.32 Billion CNY | 39.33% |
| 2018 Q1 | 383.32 Million CNY | 109.72% |
| 2018 Q3 | 359.26 Million CNY | 4.56% |
| 2018 Q4 | 233.82 Million CNY | -34.91% |
| 2018 Q2 | 343.61 Million CNY | -10.36% |
| 2017 Q1 | 258.24 Million CNY | 437.82% |
| 2017 Q4 | 182.77 Million CNY | -29.55% |
| 2017 Q2 | 246.91 Million CNY | -4.39% |
| 2017 FY | 947.39 Million CNY | 55.7% |
| 2017 Q3 | 259.45 Million CNY | 5.08% |
| 2016 Q1 | 178.99 Million CNY | 76.81% |
| 2016 Q4 | 48.01 Million CNY | -75.82% |
| 2016 Q3 | 198.61 Million CNY | 8.62% |
| 2016 Q2 | 182.85 Million CNY | 2.16% |
| 2016 FY | 608.48 Million CNY | 12.35% |
| 2015 Q2 | 154.86 Million CNY | 9.4% |
| 2015 FY | 541.59 Million CNY | 6.58% |
| 2015 Q4 | 101.23 Million CNY | -29.67% |
| 2015 Q3 | 143.94 Million CNY | -7.05% |
| 2015 Q1 | 141.55 Million CNY | -13.1% |
| 2014 Q4 | 162.89 Million CNY | 69.15% |
| 2014 FY | 508.15 Million CNY | 2.31% |
| 2014 Q1 | 132.53 Million CNY | 83.13% |
| 2014 Q3 | 96.3 Million CNY | -17.27% |
| 2014 Q2 | 116.41 Million CNY | -12.16% |
| 2013 Q1 | 128.28 Million CNY | 67.18% |
| 2013 Q2 | 135.35 Million CNY | 5.51% |
| 2013 Q3 | 160.67 Million CNY | 18.71% |
| 2013 Q4 | 72.36 Million CNY | -54.96% |
| 2013 FY | 496.68 Million CNY | 27.36% |
| 2012 Q4 | 76.73 Million CNY | -30.22% |
| 2012 Q3 | 109.95 Million CNY | 14.35% |
| 2012 Q2 | 96.15 Million CNY | -10.25% |
| 2012 Q1 | 107.14 Million CNY | 46.06% |
| 2012 FY | 389.99 Million CNY | 27.72% |
| 2011 Q4 | 73.35 Million CNY | -17.14% |
| 2011 FY | 305.33 Million CNY | 32.17% |
| 2011 Q3 | 88.53 Million CNY | 34.22% |
| 2011 Q2 | 65.95 Million CNY | -14.88% |
| 2011 Q1 | 77.49 Million CNY | 32.33% |
| 2010 FY | 231.01 Million CNY | 51.36% |
| 2010 Q3 | 60.78 Million CNY | -15.71% |
| 2010 Q2 | 72.1 Million CNY | 82.28% |
| 2010 Q4 | 58.55 Million CNY | -3.66% |
| 2010 Q1 | 39.55 Million CNY | 21.91% |
| 2009 Q4 | 32.44 Million CNY | -21.63% |
| 2009 Q2 | 47.66 Million CNY | 53.23% |
| 2009 Q1 | 31.1 Million CNY | -29.49% |
| 2009 Q3 | 41.4 Million CNY | -13.12% |
| 2009 FY | 152.62 Million CNY | -9.16% |
| 2008 Q3 | 39.77 Million CNY | -10.48% |
| 2008 Q4 | 44.11 Million CNY | 10.91% |
| 2008 FY | 168.01 Million CNY | 14.17% |
| 2008 Q1 | 39.69 Million CNY | 15.07% |
| 2008 Q2 | 44.42 Million CNY | 11.91% |
| 2007 Q4 | 34.49 Million CNY | 9.12% |
| 2007 Q3 | 31.61 Million CNY | -15.75% |
| 2007 Q2 | 37.52 Million CNY | -13.76% |
| 2007 Q1 | 43.51 Million CNY | 58.59% |
| 2007 FY | 147.15 Million CNY | 16.3% |
| 2006 Q3 | 35.9 Million CNY | 3.02% |
| 2006 Q4 | 27.43 Million CNY | -23.58% |
| 2006 Q2 | 34.84 Million CNY | 22.98% |
| 2006 FY | 126.52 Million CNY | -4.22% |
| 2006 Q1 | 28.33 Million CNY | -13.81% |
| 2005 FY | 132.1 Million CNY | 71.4% |
| 2005 Q4 | 32.87 Million CNY | -20.27% |
| 2005 Q3 | 41.23 Million CNY | 24.51% |
| 2005 Q2 | 33.12 Million CNY | 33.2% |
| 2005 Q1 | 24.86 Million CNY | 23022.19% |
| 2004 Q4 | -108.47 Thousand CNY | -100.44% |
| 2004 Q2 | 36.53 Million CNY | 129.18% |
| 2004 FY | 77.07 Million CNY | -13.82% |
| 2004 Q1 | 15.94 Million CNY | -45.71% |
| 2004 Q3 | 24.7 Million CNY | -32.38% |
| 2003 Q3 | 19.41 Million CNY | -5.42% |
| 2003 Q2 | 20.52 Million CNY | 2.02% |
| 2003 Q4 | 29.36 Million CNY | 51.23% |
| 2003 FY | 89.43 Million CNY | 0.62% |
| 2003 Q1 | 20.12 Million CNY | -21.34% |
| 2002 FY | 88.88 Million CNY | 9.78% |
| 2002 Q4 | 25.58 Million CNY | 10.48% |
| 2002 Q3 | 23.15 Million CNY | 0.0% |
| 2001 FY | 80.96 Million CNY | -3.68% |
| 2000 FY | 84.05 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 30.881% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | -330.524% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | -3996.701% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 771.6% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 9133.072% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | -127.431% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | -2855.837% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | -148.606% |